40 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
10 May 24
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
7:05am
to hire additional personnel in the areas of clinical development, quality, manufacturing, and biostatistics to support our ongoing clinical trials
8-K
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
-time stock option award to purchase 500,000 shares of the Company’s Class A ordinary shares (the “New Hire Option Award”), which shall be subject
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
21 Mar 24
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
8:00pm
, we have seen increases in cash and equity compensation costs of approximately $17.2 million as we continue to hire additional personnel in the areas
8-K
EX-99.1
l066tyozbi izef3
14 Nov 23
ProKidney Reports Third Quarter Financial Results
6:09am
424B3
2tzlj
11 Aug 23
Prospectus supplement
9:09am
8-K
EX-99.1
6zcm1q6
10 Aug 23
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
4:33pm
DEF 14A
tvk4q u2uw9bulj49
26 May 23
Definitive proxy
8:00am
424B3
kqb0aezu
26 May 23
Prospectus supplement
7:32am
424B3
1tiuj407gxpkpa
21 Apr 23
Prospectus supplement
4:18pm
POS AM
syrndlqiq k9n00q6l8k
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
k5md5g1ij9vaoknml7zt
29 Nov 22
Prospectus supplement
4:18pm
424B3
m878on
9 Sep 22
Prospectus supplement
5:05pm